Unveiling 26 Analyst Insights On Sarepta Therapeutics
Unveiling 26 Analyst Insights On Sarepta Therapeutics
揭示了26個關於sarepta therapeutics的分析師見解
The perception of Sarepta Therapeutics by financial experts is analyzed through...Ratings for Sarepta Therapeutics (NASDAQ:SRPT) were provided by 26 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，26位分析師提供了Sarepta Therapeutics（納斯達克股票代碼：SRPT）的評級，顯示了看漲和看跌的觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估，說明了過去30天不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Sarepta Therapeutics, revealing an average target of $188.31, a high estimate of $235.00, and a low estimate of $128.00. This current average reflects an increase of 7.65% from the previous average price target of $174.92.
分析師爲Sarepta Therapeutics設定了12個月的目標股價，顯示平均目標股價爲188.31美元，最高估計爲235.00美元，低估值爲128.00美元。目前的平均價格比之前的平均目標價174.92美元上漲了7.65％。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析師評級：深度分析
The perception of Sarepta Therapeutics by financial experts is analyzed through...
通過分析師最近的行動，...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間